Apotheca Integrative Pharmacy (AIP), the country’s pioneer compounding pharmacy, celebrates World Pharmacy Day with strengthened ties with pharmacist organizations and a new line of compounded solutions for Filipinos.
AIP honors the country’s hardworking pharmacists and acknowledges their contributions in improving health and pharmaceutical care in the Philippines. The company strengthens its ties with the country’s professional pharmacy organization Philippine Pharmacists Association Inc. (PPhA).
“The World Pharmacy Day is an important time for us to celebrate and recognize the efforts and contributions of every pharmacists in different pharmaceutical industry and all other stakeholders in the field. We deeply acknowledge our pharmacists at AIP who play a critical role in our advocacy for the Pharmacy Triad along with doctors and patients. This is how we continue to serve Filipinos with high-quality compounded medications,” said AIP Managing Director Sofia Lista.
Leading quality and innovation in the compounding space
AIP, the pioneer FDA-licensed specialty compounding pharmacy in the country, consistently upholds and promotes accountability between doctors, patients and pharmacists, also better known as the Pharmacy Triad. This enables AIP to continuously serve the public through high-quality compounded medications and superior pharmaceutical care and in so doing be their trusted healthcare partner.
AIP compounds medications based on prescription, mixing individual ingredients in the exact strength and dosage form as required by the doctor. To date, AIP has grown its portfolio to more than 950 active formulas being compounded per prescription from its database of 2,500 formulas. It has served over 1,600 medical doctors and more than 15,000 patients and has supplied over 115,000 quality prescriptions.
AIP is currently recommended by more than 100 hospitals across the country, specifically in the pediatric category.
Establishing stronger ties in the industry
AIP seeks to amplify its presence by building long-term relationships within the industry, pursuing shared goals and sharing industry best practices.
The specialty compounding pharmacy continues to work with the PPhA, the integrated national organization of licensed Filipino pharmacists, and other organizations in the field to help advance pharmacy practice in the country. Participating in PPhA-mounted events such as the 2022 PPhA National Convention and the recently concluded PPhA’s 102nd Anniversary Event also enables AIP pharmacists to develop their knowledge and skills.
As part of AIP’s goals to collaborate with more industry players whether from the private or public sector, AIP CEO Richard Lista recently met with former and present PPhA Presidents Leonila M. Ocampo and Ma. Gilda Sebua-Saljay, respectively, to discuss AIP’s compounded medications. AIP was also invited to grace PPhA National Convention in 2023 as a thought leader in the field.
AIP also recently collaborated with pharmacy preceptor group (PPGP), the first and only organization of its kind in the country. Just recently, PPGP invited AIP Managing Director Sofia Lista and Operations Department Supervisor Rachelle K. Austria, RPh as speakers at PPGP’s Third General Assembly, where the executives’ shared their best practices, business model and updates on pharmaceutical innovations on customized compounding as part of the community pharmacy industry.
World-class integrative pharmacy
AIP further expands its product portfolio with new compounded formulations. These new solutions form part of the company’s existing categories of compounded medications, namely Bio-identical Hormone Replacement Therapy (BHRT), Weight Loss Management, Intravenous (IV) Nutrition, Thyroid Medication, Erectile Dysfunction, Pain Management, Hair Loss, Dermatological Preparations, Pediatrics and Nutraceuticals.
AIP’s new solutions for weight loss management include Bupropion and Naltrexone Capsules, a prescribed medication not readily available in the local market. Studies have shown that this combination helps to improve weight loss. It also helps curb appetite and food cravings. On the other hand, Bupropion is known as an antidepressant that helps suppress appetite, while Naltrexone is used for patients with alcohol addiction problems. These medicines require direct medical supervision and are not advised for pregnant women and those who have uncontrolled high blood pressure, seizures and eating disorders.
AIP’s new compounded skin medications now include a Coenzyme Q10 Cream developed for the reduction of fine lines and wrinkles from photo-aged skin, where active ingredients are found to be beneficial with regard to effective Q10 replenishment. Another skin solution is the Nicotinamide Adenine Dinucleotide (NAD+) which is a cream that is an effective topical antipsoriatic agent (psoriasis rashes).
AIP also offers Phosphatidylcholine parental solutions, which are injected by healthcare practitioners under the skin as it can treat excess fat around the eyelids and yellowish cholesterol deposits under the surface of the skin. On a more foundational level, these can also help improve overall brain health, liver function, male sexual function and immune system.
All compounded medication solutions require a doctor’s prescription. All of AIP’s products are made only with United States Pharmacopeia (USP) grade active ingredients to assure its high-quality.